Physician profile

John H Chaney

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Lexington, KY

NPI 1033377049

$15,468.56

in general payments reported to CMS, 2019-2025

27 companies · $2,133 in 2025

The $2,133 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$5,500.00
Food and Beverage$3,706.22
Travel and Lodging$3,455.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $8,165.22 2023 Davinci Xi, Da Vinci Surgical System
Atricure, INC. $1,877.84 2019-2025 Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax
Abbott Laboratories $1,741.71 2019-2025 Triclip, Epic, Mitraclip
W. L. Gore & Associates, INC. $837.32 2020-2025 Gore Tag Thoracic Branch Endoprosthesis, C3 Delivery System, Gore Excluder Thoracoabdominal Branch Endoprosthesis
Edwards Lifesciences Corporation $752.78 2019-2025 Sapien 3 Ultra Resilia, Konect Resilia, Mitris Resilia Mitral Valve
Boston Scientific Corporation $585.90 2020-2023
Getinge USA Sales, LLC $193.64 2023-2025 Vasoview Hemopro 2, Cardiosave Rescue, Vasoview Hemopro 2
Merck Sharp & Dohme LLC $186.14 2019-2024 Keytruda
Baxter Healthcare $176.40 2024 Preveleak
Medtronic, INC. $113.30 2023-2025 Corevalve Evolut R, Penditure, Endurant Iis
Angiodynamics, INC. $97.49 2020-2023 Alphavac
Zimmer Biomet Holdings, INC. $95.78 2019-2021
Olympus America INC. $81.04 2020-2023 Evis Exera III Bronchovideoscope, Evis Exera II Ultrasonic Bronchofibervideoscope, 4k Cable 8.5m
Corcym INC $66.02 2023-2025 Perceval
Shockwave Medical, INC $62.35 2023-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Show all 27 companies
CompanyGeneral paymentsYearsTop products
Kls-Martin L.P. $59.43 2021-2024
Lsi Solutions INC $52.91 2019-2022
Galvanize Therapeutics, INC $48.89 2024 Aliya System
Surmodics, INC. $44.45 2025 Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight
Cook Medical LLC $41.17 2020-2021
Ethicon US, LLC $40.04 2019-2023 Echelon; Endopath
Innovation Technologies INC $35.97 2024 Irrisept
Veran Medical Technologies, INC. $28.46 2021
Legacy Ortho LLC $25.97 2023
Silk Road Medical, INC. $23.25 2022
Astrazeneca Pharmaceuticals LP $20.15 2023 Tagrisso
Cardiovascular Systems INC. $14.94 2023 Diamondback Peripheral

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John H Chaney

$15,468.56

in general payments reported 2019-2025

Years
2019-2025
Top company
Intuitive Surgical, INC.
Context
The $2,133 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/1342664/john-h-chaney

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.